ArticleArchives of toxicology2026
Arsenic disrupts autophagosome-lysosome fusion in a zinc dependent manner across multiple human skin and lung cells lines.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Chronic environmental arsenic exposure causes skin and lung cancers, but the molecular mechanisms are poorly understood. We identified that chronic trivalent inorganic arsenite (iAs) exposure at population relevant 100 nM concentration activates autophagy while suppressing downstream protein degradation. Here, we studied the mechanisms by which environmental iAs exposure uncouples autophagy activation from autophagic protein degradation across human skin and lung cell lines. During autophagy, zinc regulates the critical autophagosome-lysosome fusion (ALF) step connecting initiation to final protein degradation. iAs disrupts zinc dependent processes. Thus, we hypothesized that iAs suppresses autophagy by compromising ALF. We demonstrate that environmental 100 nM iAs exposure specifically targets the ALF step of autophagy to suppress autophagic protein degradation across multiple skin and lung cell line models. We show that iAs suppresses ALF in a zinc dependent manner. Physiological zinc supplementation (1 μM) prevented and rescued against iAs-induced suppression of ALF and autophagic protein degradation in the short and long-term. Our work provides a framework to understand and further investigate the precise molecular mechanisms by which chronic environmental iAs exposure disrupts global protein degradation, thereby inducing proteotoxicity across multiple target tissues and contributing to the observed proteome-wide differential expression patterns during multi-organ carcinogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.